We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+6.17%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$144B
AUM Growth
+$27.9B
Cap. Flow
+$22.2B
Cap. Flow %
15.4%
Top 10 Hldgs %
31.02%
Holding
7,740
New
680
Increased
3,884
Reduced
2,259
Closed
408

Sector Composition

Rank Sector Weight
1 Technology 8.24%
2 Financials 5.68%
3 Healthcare 5.62%
4 Consumer Discretionary 5.04%
5 Industrials 3.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NDAQ icon
5251
CALL
Nasdaq
NDAQ
$53.1B
$129K ﹤0.01%
4,500
-1,800
-29% -$55.4K
NKSH icon
5252
National Bankshares
NKSH
$269M
$129K ﹤0.01%
2,826
+2,331
+471% +$108K
PSI icon
5253
Invesco Semiconductors ETF
PSI
$2.48B
$129K ﹤0.01%
7,260
RDFN
5254
CALL
DELISTED
Redfin
RDFN
$129K ﹤0.01%
6,900
-8,500
-55% -$180K
AVEO
5255
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$129K ﹤0.01%
3,894
+3,148
+422% +$80.9K
FOSL icon
5256
PUT
Fossil Group
FOSL
$310M
$128K ﹤0.01%
5,500
-19,600
-78% -$494K
INDY icon
5257
iShares S&P India Nifty 50 Index Fund
INDY
$565M
$128K ﹤0.01%
3,750
-15,000
-80% -$545K
PBYI icon
5258
CALL
Puma Biotechnology
PBYI
$453M
$128K ﹤0.01%
2,800
-57,200
-95% -$2.76M
VLRS
5259
Controladora Vuela Compania de Aviacion
VLRS
$907M
$128K ﹤0.01%
17,200
+12,200
+244% +$87.2K
HSBC.PRA
5260
DELISTED
HSBC Holdings PLC, Inc. ADS(1/40 shr. 6.2% Non-Cum. Dlr. Pref. Shrs., Ser.A)
HSBC.PRA
$128K ﹤0.01%
5,000
GEF.B icon
5261
Greif Class B
GEF.B
$4.23B
$127K ﹤0.01%
2,203
+1,797
+443% +$105K
STGW icon
5262
Stagwell
STGW
$2.27B
$127K ﹤0.01%
30,524
+23,391
+328% +$114K
XELA
5263
DELISTED
Exela Technologies, Inc. Common Stock
XELA
$127K ﹤0.01%
+1
New +$67.6K
SRT
5264
DELISTED
Startek Inc.
SRT
$126K ﹤0.01%
18,989
-16,317
-46% -$108K
BSTC
5265
DELISTED
BioSpecifics Technologies Corp.
BSTC
$126K ﹤0.01%
2,156
+1,742
+421% +$88.9K
LBRDA icon
5266
Liberty Broadband Class A
LBRDA
$5.33B
$125K ﹤0.01%
1,486
+454
+44% +$36.1K
SAFT icon
5267
CALL
Safety Insurance
SAFT
$1.52B
$125K ﹤0.01%
+1,400
New +$129K
TXRH icon
5268
CALL
Texas Roadhouse
TXRH
$13.8B
$125K ﹤0.01%
1,800
+1,000
+125% +$67.9K
ABB
5269
CALL
DELISTED
ABB Ltd
ABB
$125K ﹤0.01%
5,300
-60,700
-92% -$1.39M
CALA
5270
DELISTED
Calithera Biosciences, Inc
CALA
$125K ﹤0.01%
1,197
+804
+205% +$76.6K
KDMN
5271
DELISTED
Kadmon Holdings, Inc.
KDMN
$125K ﹤0.01%
37,363
+32,265
+633% +$114K
GLUU
5272
CALL
DELISTED
Glu Mobile Inc.
GLUU
$125K ﹤0.01%
16,800
-12,900
-43% -$86.9K
KAACW
5273
DELISTED
Kayne Anderson Acquisition Corp.
KAACW
$125K ﹤0.01%
+100,000
New +$148K
ANIP icon
5274
CALL
ANI Pharmaceuticals
ANIP
$1.71B
$124K ﹤0.01%
2,200
+2,000
+1,000% +$122K
CIVB icon
5275
Civista Bancshares
CIVB
$592M
$124K ﹤0.01%
5,131
+4,396
+598% +$107K

Similar funds

Barclays's Q3 2018 Portfolio in Review

As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.

By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.

  • Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
  • Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
  • Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
  • Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
  • Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
  • Barclays opened 680 new positions and closed 408 in Q3 2018.
  • Barclays's portfolio value rose 24% quarter-over-quarter to $144B.

Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.